Indication
Receptors
3 clinical trials
3 products
Product
PalbociclibClinical trial
An Open-Label Multicenter Phase 1b Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive HER2-Negative Breast CancerStatus: Active (not recruiting), Estimated PCD: 2022-09-16
Product
H3B-6545Clinical trial
Phase 1 Study of Erdafitinib Intravesical Delivery System (TAR-210) in Participants With Non- Muscle-Invasive or Muscle-Invasive Bladder Cancer and Selected FGFR Mutations or FusionsStatus: Recruiting, Estimated PCD: 2028-03-30
Product
ErdafitinibClinical trial
A Phase 1 Study to Evaluate the Tolerability, Safety, and Pharmacokinetics of TAR-210 in Japanese Participants With Bladder Cancer and Selected FGFR Mutations or FusionsStatus: Recruiting, Estimated PCD: 2026-10-16